Regeneron Pharmaceuticals, Inc. (REGN)
786.52
-2.92
(-0.37%)
USD |
NASDAQ |
Sep 18, 14:33
Regeneron Pharmaceuticals 30-Day Average Daily Volume : 656937.0 for Sept. 17, 2026
30-Day Average Daily Volume Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| September 17, 2026 | 656937.0 |
| September 16, 2026 | 651259.2 |
| September 15, 2026 | 665737.1 |
| September 14, 2026 | 675800.2 |
| September 11, 2026 | 694709.8 |
| September 10, 2026 | 728609.0 |
| September 09, 2026 | 745126.0 |
| September 08, 2026 | 754424.3 |
| September 04, 2026 | 757572.6 |
| September 03, 2026 | 762480.0 |
| September 02, 2026 | 783585.2 |
| September 01, 2026 | 787675.8 |
| August 31, 2026 | 782575.0 |
| August 28, 2026 | 773592.4 |
| August 27, 2026 | 778928.9 |
| August 26, 2026 | 777704.1 |
| August 25, 2026 | 776705.8 |
| August 24, 2026 | 775791.3 |
| August 21, 2026 | 773601.0 |
| August 20, 2026 | 766762.9 |
| August 19, 2026 | 769298.0 |
| August 18, 2026 | 769177.6 |
| August 17, 2026 | 773839.7 |
| August 14, 2026 | 779607.5 |
| August 13, 2026 | 801140.9 |
| Date | Value |
|---|---|
| August 12, 2026 | 816504.6 |
| August 11, 2026 | 824696.6 |
| August 10, 2026 | 817874.6 |
| August 07, 2026 | 817869.1 |
| August 06, 2026 | 813177.9 |
| August 05, 2026 | 815044.0 |
| August 04, 2026 | 839956.9 |
| August 03, 2026 | 866190.8 |
| July 31, 2026 | 925075.1 |
| July 30, 2026 | 929778.7 |
| July 29, 2026 | 914662.0 |
| July 28, 2026 | 907777.3 |
| July 27, 2026 | 901689.7 |
| July 24, 2026 | 911429.3 |
| July 23, 2026 | 915019.9 |
| July 22, 2026 | 917061.5 |
| July 21, 2026 | 929963.6 |
| July 20, 2026 | 944830.6 |
| July 17, 2026 | 956495.7 |
| July 16, 2026 | 967771.9 |
| July 15, 2026 | 978997.3 |
| July 14, 2026 | 996493.6 |
| July 13, 2026 | 1.053M |
| July 10, 2026 | 1.074M |
| July 09, 2026 | 1.119M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Alnylam Pharmaceuticals, Inc. | 1.644M |
| AbbVie, Inc. | 4.313M |
| Gilead Sciences, Inc. | 5.607M |
| Amgen, Inc. | 2.520M |
| Biogen, Inc. | 739073.4 |